Review article · 12 May 2026
Review articlePublished 21 Jan 2012
GLP 1 and Macrovascular Complications
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Type two diabetes remains to be one of the most challenging chronic diseases affecting 26 million people in the United States. Despite advances in the management of this illness, a large number of diabetics suffer from disease related complications. Heart disease and stroke account for a significant percentage of death in diabetics. Advancing treatment options for diabetics beyond glycemic control and Hba1c levels to prevent macrovascular complications should be the target of our management. GLP1, a member of the pro-glucagon incretin family, and GLP1 analogues seems to have beneficial effects on the macrovascular levels, in addition to their established effect on the glycemic control. This article reviews the potential effect of GLP1 family on the macrovascular complications including cardiovascular, cerebrovascular, and peripheral vascular diseases.
Keywords
Subjects
General & Internal MedicineAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Internal Medicine.
Mini review · 10 Mar 2026
Low-Dose Aspirin in Coronary Artery Disease: Evidence and Implications
Mini review · 15 Feb 2026
Extracellular Vesicles: A Key Regulator of Macrophage Polarization During Bacterial Infection
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternal Medicine
- SubjectGeneral & Internal Medicine
- BylineArticles whose byline prints “Dana Sleiman”
- BylineArticles whose byline prints “Sami T. Azar”